Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escin as add-on treatment for COVID-19
NCT04322344Phase 3Unknown
- Sponsor
- University of Magna Graecia
- Start
- Mar 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escin in coronavirus disease 2019 (COVID-19), sponsored by University of Magna Graecia. Status: unknown.
02
Drugs
escin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04322344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322344.